SCHEMBL6983698

SCHEMBL6983698

CCN(CC)C(=O)c1ccc2c(c1)CCCN2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.62
MAPT P10636 2/20 0.62
ALDH1A1 P00352 3/20 0.55
TDP1 Q9NUW8 2/20 0.55
ALOX15 P16050 2/20 0.55
LMNA P02545 2/20 0.55
GAA P10253 2/20 0.55
TP53 P04637 1/20 0.55
THRB P10828 1/20 0.55
CASP1 P29466 1/20 0.55
HTT P42858 1/20 0.55
CASP7 P55210 1/20 0.55
HSD17B10 Q99714 1/20 0.55
HSP90AA1 P07900 5/20 0.46
HSP90AB1 P08238 5/20 0.46
HPGD P15428 3/20 0.44
OPRD1 P41143 5/20 0.44
OPRM1 P35372 4/20 0.44
OPRK1 P41145 4/20 0.44
CA12 O43570 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21042092 0.92 ALDH1A1 (0.50) KDM4EMAPTALDH1A1TDP1ALOX15
Hydrochloric Acid SCHEMBL28873434 0.90 ALDH1A1 (0.49) KDM4EMAPTALDH1A1TDP1ALOX15
SCHEMBL45780 0.84 KDM4E (0.68) KDM4EMAPTALDH1A1TDP1ALOX15
SCHEMBL3096482 0.79 MAPT (0.73) KDM4EMAPTALDH1A1TDP1ALOX15
SCHEMBL30853462 0.78 MAPT (0.62) KDM4EMAPTALDH1A1TDP1ALOX15
SCHEMBL4682191 0.78 MAPT (0.62) KDM4EMAPTALDH1A1TDP1ALOX15
SCHEMBL6986243 0.77 KDM4E (0.62) KDM4EMAPTALDH1A1TDP1ALOX15
SCHEMBL29673258 0.77 KDM4E (1.00) KDM4EMAPTALDH1A1TDP1ALOX15
SCHEMBL45202 0.77 KDM4E (1.00) KDM4EMAPTALDH1A1TDP1ALOX15
SCHEMBL30011603 0.76 KDM4E (0.73) KDM4EMAPTALDH1A1TDP1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed